ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,679 | -75.9% | 19,643 | -64.9% | 0.00% | -100.0% |
Q2 2023 | $164,923 | +50.7% | 55,906 | +62.0% | 0.00% | 0.0% |
Q4 2022 | $109,409 | +20.2% | 34,514 | +13.1% | 0.00% | 0.0% |
Q3 2022 | $91,000 | -25.4% | 30,524 | -23.8% | 0.00% | 0.0% |
Q2 2022 | $122,000 | -57.3% | 40,076 | +89.1% | 0.00% | -50.0% |
Q1 2022 | $286,000 | -33.2% | 21,198 | -35.5% | 0.00% | -50.0% |
Q4 2021 | $428,000 | +24.8% | 32,844 | -10.2% | 0.00% | 0.0% |
Q3 2021 | $343,000 | +139.9% | 36,567 | +161.1% | 0.00% | +100.0% |
Q2 2021 | $143,000 | +155.4% | 14,007 | +361.7% | 0.00% | +100.0% |
Q1 2021 | $56,000 | – | 3,034 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |